PlainRecalls
FDA Devices Critical Class I Ongoing

Philips OmniLab Advanced+ Intl (Flow Gen), Rx Only. To provide noninvasive ventilation support for patients with obstructive sleep apnea syndrome (OSA) and respiratory insufficiency.

Reported: September 14, 2022 Initiated: August 26, 2022 #Z-1658-2022

Product Description

Philips OmniLab Advanced+ Intl (Flow Gen), Rx Only. To provide noninvasive ventilation support for patients with obstructive sleep apnea syndrome (OSA) and respiratory insufficiency.

Reason for Recall

Motor assemblies manufactured with nonconforming plastic that contributes to off-gassing of VOCs.

Details

Recalling Firm
Philips Respironics, Inc.
Units Affected
34 units ***updated January 2024 *** additional 3 units
Distribution
Domestic: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, MS, MT, NC, ND, NH, NJ, NV, NY, OH, OK, OR, PA, TN, TX, VA, VT, WA, WI, WV, & WY. Foreign: Australia, Austria, Bangladesh, Brazil, Canada, China, Denmark, Egypt, France, Germany, Hong Kong, Hungary, India, Israel, Italy, Japan, Malaysia, Mexico, Myanmar, Philippines, Qatar, Serbia, Singapore, Taiwan, Thailand, Turkey, UAE, & UK.
Location
Murrysville, PA

Frequently Asked Questions

What product was recalled?
Philips OmniLab Advanced+ Intl (Flow Gen), Rx Only. To provide noninvasive ventilation support for patients with obstructive sleep apnea syndrome (OSA) and respiratory insufficiency.. Recalled by Philips Respironics, Inc.. Units affected: 34 units ***updated January 2024 *** additional 3 units.
Why was this product recalled?
Motor assemblies manufactured with nonconforming plastic that contributes to off-gassing of VOCs.
Which agency issued this recall?
This recall was issued by the FDA Devices on September 14, 2022. Severity: Critical. Recall number: Z-1658-2022.